Vanda Pharmaceuticals (VNDA) P/E US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/E | ? | 7.55 | 30.6 | 26.3 | 66.5 | 96.5 | -15.9 | ||
Changes by years, y/y, % | -86% | +306% | -14% | +153% | +45% | +12.9% |
Vanda Pharmaceuticals. P/E
Vanda Pharmaceuticals. P/E, changes, %
Vanda Pharmaceuticals (VNDA) P/E US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
P/E | ? | 21.1 | 96.8 | -48.6 | -30.1 | -16.7 | -15.9 | |
Changes by years, y/y, % | -75% | +45% | -300% | -218% | -179% | |||
Changes by quarters, q/q, % | -17% | +358% | -150% | -38% | -45% |